IMUX Earnings

Quarterly EPS
$-2.40
Q3 2024
$-2.50
Q4 2024
$-2.51
Q1 2025
$-2.03
Q2 2025
$-1.30
Q3 2025
$-0.48
Q4 2025
$-1.08
Q1 2026
$-0.80
Q2 2026
Latest RevenueN/A
Latest Net Income-34099000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.800-34099000+60.6%
Q1 2026-$1.080-32588000+57.0%
Q4 2025-$0.480-19300000+80.8%
Q3 2025-$1.300-25579000+45.8%
Q2 2025-$2.030-26820000+3.3%
Q1 2025-$2.510-25473000+16.3%
Q4 2024-$2.500-25175000+48.3%
Q3 2024-$2.400-24368000+52.9%
Q2 2024-$2.100-21380000
Q1 2024-$3.000-29584000
Q4 2023-$4.840-21572000
Q3 2023-$5.100-22769000
Immunic (IMUX) — Earnings